Autobahn Labs bringing industrial translation to academic projects via joint ownership model, starting with UCLA

Virtual incubator Autobahn Labs goes in on projects too early for traditional tech transfer

Virtual incubator Autobahn Labs aims to industrialize academic projects deemed too early for traditional tech transfer by running them through Evotec’s drug discovery funnel, with the goal of creating jointly owned spinouts backed by Autobahn’s investors.

Launched Wednesday by Samsara Biocapital, Evotec SE and the family investment fund KCK Ltd., Autobahn announced a partnership with University of

Read the full 567 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE